Cargando…

Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study

BACKGROUND: Although bacteremia is one of the most pressing situation in the field of hospital medicine, little is known about the differences between community‐ and hospital‐acquired bacteremia (CAB and HAB, respectively). METHODS: Objective is to know the epidemiologic characteristics of CAB and H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakabayashi, Takao, Iwata, Hiroyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561096/
https://www.ncbi.nlm.nih.gov/pubmed/34754710
http://dx.doi.org/10.1002/jgf2.453
_version_ 1784593059569205248
author Wakabayashi, Takao
Iwata, Hiroyoshi
author_facet Wakabayashi, Takao
Iwata, Hiroyoshi
author_sort Wakabayashi, Takao
collection PubMed
description BACKGROUND: Although bacteremia is one of the most pressing situation in the field of hospital medicine, little is known about the differences between community‐ and hospital‐acquired bacteremia (CAB and HAB, respectively). METHODS: Objective is to know the epidemiologic characteristics of CAB and HAB. Study design is a single‐center retrospective cohort study. Participants were all patients over the age of 16 years who were blood cultures positive at single acute care hospital from April 2013 to March 2018. HAB was defined as positive culture acquired at least 48 h after admission or blood culture‐positive patients transferred from other hospital. The primary outcome was 30 day mortality, and the secondary outcome was 1 year mortality. We compared the primary and secondary outcomes between HAB and CAB using logistic regression analyses. RESULTS: There were 325 participants in this study. The number of patients with CAB was 189 (58.1%). HAB was associated with a higher 30 day mortality rate than CAB (n = 31, 22.8% vs. n = 9, 4.8%, adjusted odds ratio (AOR) 2.60; 95% confidence interval (CI) 1.04–6.53, p < 0.05). In the secondary outcome, HAB was also associated with a higher 1 year mortality rate (n = 61/110, 55.5% vs. n = 32/143, 22.4%, AOR 2.27; 95% CI: 1.12–4.58). CONCLUSIONS: Our study showed that HAB was associated with higher mortality than CAB in 30 day mortality and in 1 yr mortality. Thus, we confirmed that HAB is distinct from CAB concerning the differences of outcomes.
format Online
Article
Text
id pubmed-8561096
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85610962021-11-08 Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study Wakabayashi, Takao Iwata, Hiroyoshi J Gen Fam Med Original Articles BACKGROUND: Although bacteremia is one of the most pressing situation in the field of hospital medicine, little is known about the differences between community‐ and hospital‐acquired bacteremia (CAB and HAB, respectively). METHODS: Objective is to know the epidemiologic characteristics of CAB and HAB. Study design is a single‐center retrospective cohort study. Participants were all patients over the age of 16 years who were blood cultures positive at single acute care hospital from April 2013 to March 2018. HAB was defined as positive culture acquired at least 48 h after admission or blood culture‐positive patients transferred from other hospital. The primary outcome was 30 day mortality, and the secondary outcome was 1 year mortality. We compared the primary and secondary outcomes between HAB and CAB using logistic regression analyses. RESULTS: There were 325 participants in this study. The number of patients with CAB was 189 (58.1%). HAB was associated with a higher 30 day mortality rate than CAB (n = 31, 22.8% vs. n = 9, 4.8%, adjusted odds ratio (AOR) 2.60; 95% confidence interval (CI) 1.04–6.53, p < 0.05). In the secondary outcome, HAB was also associated with a higher 1 year mortality rate (n = 61/110, 55.5% vs. n = 32/143, 22.4%, AOR 2.27; 95% CI: 1.12–4.58). CONCLUSIONS: Our study showed that HAB was associated with higher mortality than CAB in 30 day mortality and in 1 yr mortality. Thus, we confirmed that HAB is distinct from CAB concerning the differences of outcomes. John Wiley and Sons Inc. 2021-05-14 /pmc/articles/PMC8561096/ /pubmed/34754710 http://dx.doi.org/10.1002/jgf2.453 Text en © 2021 The Authors. Journal of General and Family Medicine published by John Wiley & Sons Australia, Ltd on behalf of Japan Primary Care Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Wakabayashi, Takao
Iwata, Hiroyoshi
Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study
title Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study
title_full Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study
title_fullStr Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study
title_full_unstemmed Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study
title_short Outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: A retrospective cohort study
title_sort outcome, diagnosis, and microbiological profile comparison of community‐ and hospital‐acquired bacteremia: a retrospective cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561096/
https://www.ncbi.nlm.nih.gov/pubmed/34754710
http://dx.doi.org/10.1002/jgf2.453
work_keys_str_mv AT wakabayashitakao outcomediagnosisandmicrobiologicalprofilecomparisonofcommunityandhospitalacquiredbacteremiaaretrospectivecohortstudy
AT iwatahiroyoshi outcomediagnosisandmicrobiologicalprofilecomparisonofcommunityandhospitalacquiredbacteremiaaretrospectivecohortstudy